Search Results
Test Catalog
BFBL - Overview: Bilirubin, Body Fluid
Evaluating peritoneal fluid or abdominal drain fluid as a screening test for bile leakage May aid in the distinction between a transudative and an exudative pleural effusion
C3FX - Overview: C3 Complement, Functional, Serum
Diagnosis of C3 deficiency Investigation of a patient with undetectable total complement level
CRWB - Overview: Chromium, Blood
Monitoring exposure to chromium using whole blood specimens Monitoring metallic prosthetic implant wear
C7FX - Overview: C7 Complement, Functional, Serum
Diagnosis of C7 deficiency Investigation of a patient with an undetectable total complement level
HMNA - Overview: Heavy Metals, Nails
Detection of nonacute arsenic, mercury, and lead exposure
HEPTP - Overview: Heparin Anti-Xa, Plasma
Measuring heparin concentration: -In patients treated with low-molecular-weight heparin preparations -In the presence of prolonged baseline activated partial thromboplastin time (APTT) (eg, lupus anticoagulant, "contact factor" deficiency,...
Aiding in the evaluation of iron deficiency and iron overload diseases in combination with total iron binding capacity and percent saturation Assessment of acute iron poisoning
CASF - Overview: IgG/Albumin Ratio, Spinal Fluid
Assessment of cerebrospinal fluid (CSF) IgG/albumin ratio in the absence of a paired CSF and serum specimen
THCG - Overview: Human Chorionic Gonadotropin (hCG), Quantitative, Pregnancy, Serum
Early detection of pregnancy Investigation of suspected ectopic pregnancy or other pregnancy-related complications Monitoring in vitro fertilization patients This test is not useful for detecting or monitoring tumors or gestational...
HQ - Overview: HemoQuant, Feces
Detection of blood in feces Evaluation of iron deficiency Detection of bleeding as a complication of anticoagulant therapy and other medication regimens This test is not specific for bowel cancer.
HEPBS - Overview: Hepatitis B Surface (HBs) Antigen Immunostain, Technical Component Only
Aiding in the identification of hepatitis B infection (carrier state)
IMIPR - Overview: Imipramine and Desipramine, Serum
Monitoring imipramine and desipramine concentrations during therapy Evaluating potential imipramine and desipramine toxicity May aid in evaluating patient compliance
CD35 - Overview: CD35 Immunostain, Technical Component Only
Identification of follicular dendritic cells and granulocytes
CD25 - Overview: CD25 Immunostain, Technical Component Only
Classification of lymphomas
CD23 - Overview: CD23 Immunostain, Technical Component Only
Identification of follicular dendritic cells Classification of low-grade B-cell lymphomas
CD3I - Overview: CD3 Immunostain, Technical Component Only
Demonstrating T-cell lineage
CD10 - Overview: CD10 Immunostain, Technical Component Only
Phenotyping leukemias and lymphomas
CEAPT - Overview: Carcinoembryonic Antigen (CEA), Peritoneal Fluid
An adjunct to cytology to differentiate between malignancy-related and benign causes of ascites formation
CRCRU - Overview: Chromium/Creatinine Ratio, Random, Urine
Detecting chromium exposure
Aiding in the diagnosis of California (La Crosse) encephalitis using spinal fluid specimens
CD11C - Overview: CD11c Immunostain, Technical Component Only
Aiding in the diagnosis of hematological malignancies and identification of cells of the macrophage/dendritic cell lineage within tissues
GBM - Overview: Glomerular Basement Membrane Antibodies, IgG, Serum
Evaluating patients with clinical features of anti-glomerular basement disease, including rapidly progressive glomerulonephritis or pulmonary hemorrhage
Determining class II human leukocyte antigens (HLA) to identify potential disease associations or markers for drug hypersensitivity
Determining class I human leukocyte antigens (HLA) on specimens for those patients who have become refractory to platelet transfusions and identify potential disease associations or markers for drug hypersensitivity
THEVI - Overview: Hemoglobinopathy Interpretation
Interpretation of results for the evaluation of thalassemias and hemoglobinopathies Evaluation of microcytosis Extensive and economical diagnosis and classification of hemoglobinopathies or thalassemia including complex...
GCDF - Overview: GCDFP-15 Immunostain, Technical Component Only
Aiding in the identification of extramammary Paget disease, carcinomas of the salivary glands, sweat glands, and prostate
HBELI - Overview: Hemoglobin Electrophoresis Interpretation
Interpretation for the results of hemoglobin electrophoresis Diagnosis and classification of hemoglobin disorders, including thalassemias and hemoglobin variants
MERKC - Overview: Merkel CC (MCPyV) Immunostain, Technical Component Only
Identification of Merkel cell polyomavirus infected cells
NEUD1 - Overview: Neuronal Differentiation 1 (NeuroD1), Technical Component only
Subclassification of small cell lung carcinoma
NIUC - Overview: Nickel/Creatinine Ratio, Random, Urine
Measurement of nickel concentration for biomonitoring nickel exposure
OXYSU - Overview: Oxycodone Screen, Random, Urine
Detection of oxycodone and oxymorphone in urine
MYCOG - Overview: Mycoplasma pneumoniae Antibodies, IgG, Serum
Screening for IgG antibodies in the indication of recent or past exposure to Mycoplasma pneumoniae
PAX2 - Overview: PAX2 Immunostain, Technical Component Only
Aiding in the diagnosis of endocervical adenocarcinoma and renal cell carcinoma
P504S - Overview: P504S Immunostain, Technical Component Only
Characterization of renal cell carcinoma and the identification of high-grade prostatic intraepithelial neoplasia and prostate carcinoma
PLAIF - Overview: Phospholipase A2 Receptor (PLA2R), Renal Biopsy
Distinguishing primary membranous nephropathy from secondary membranous nephropathy
PARVM - Overview: Parvovirus B19 Antibody, IgM, Serum
Serologic detection of recent or past parvovirus B19 infection using IgM antibodies This test is not useful as a screening procedure for the general population.
PARVG - Overview: Parvovirus B19 Antibodies, IgG, Serum
Serologic detection of recent or past parvovirus B19 infection using IgG antibodies This test is not useful as a screening procedure for the general population.
PRAME - Overview: PRAME Immunostain, Technical Component Only
Differentiation between melanoma and benign nevi.
P63 - Overview: p63 Immunostain, Technical Component Only
Aiding in identifying squamous, urothelial, or myoepithelial differentiation in tumors
PLAP - Overview: Placental Alkaline Phosphatase (PLAP) Immunostain, Technical Component Only
Aids in the identification of germ cell tumors
POU2F - Overview: POU2F3 Immunostain, Technical Component Only
Diagnosis of a variant of small cell lung carcinoma
CO4D - Overview: Complement 4d Immunostain, Technical Component Only
Identification of antibody-mediated transplant rejection
CRPRO - Overview: C-Reactive Protein (CRP) Immunostain, Technical Component Only
Classification of hepatic adenomas
CMVI - Overview: Cytomegalovirus (CMV) Immunostain, Technical Component Only
Identification of cytomegalovirus infection
CLAUD - Overview: Claudin-1 Immunostain, Technical Component Only
Identification of a number of different soft tissue and epithelial neoplasms
CHRO - Overview: Chromogranin Immunostain, Technical Component Only
Aiding in the identification of tumors with neuroendocrine differentiation
DIG - Overview: Digoxin, Serum
Monitoring digoxin therapy
CHIKG - Overview: Chikungunya IgG, Antibody, Serum
Aiding in the diagnosis of recent infection with Chikungunya virus detecting IgG antibodies in patients with recent travel to endemic areas and a compatible clinical syndrome
CHIKM - Overview: Chikungunya IgM, Antibody, Serum
Aiding in the diagnosis of recent infection with Chikungunya virus detecting IgM antibodies in patients with recent travel to endemic areas and a compatible clinical syndrome
Site Search
Information: Interpreting Laboratory Tests to Determine New vs. Residual Use of Marijuana - Insights
In this month's "Hot Topic," Paul Jannetto, Ph.D., identifies how to determine new vs. residual use of marijuana in a patient, and teaches how to calculate the carboxy-tetrahydrocannabinol (carboxy-THC)...
Laboratory and Pathology Research Roundup: March 12 - Insights
known. We performed laser microdissection (LCM) of glomeruli followed by mass spectrometry (MS) in 12 cases each of DDD, C3GN, and pretransplant kidney control biopsies....
COVID-19: At-home sample collection vs. at-home testing - Insights
The concept of at-home testing for COVID-19 sounds straightforward. But there's nuance to it that's important to understand. Right now, an at-home test for COVID-19 is not available, although there may be one coming soon. But in some areas,...
Transfusion Toons: A1 vs. A2 - Insights
Justin Kreuter, M.D., Clinical Pathologist and Medical Director of the Mayo Clinic Blood Donor Center in Rochester, Minnesota, and Theresa Malin, an Education Specialist in Transfusion Medicine at Mayo Clinic, have launched “Transfusion...
Clinic Laboratory and Pathology Research Roundup: Nov. 12 - Insights
This week’s Research Roundup highlights a mechanism for preventing asymmetric histone segregation onto replicating DNA strands.